TELA Bio announced that Roberto Cuca, its Chief Operating Officer and Chief Financial Officer, will step down from his role. The company also revealed a headcount reduction of approximately 20% as part of a strategic cost reduction initiative. TELA Bio expects to incur a one-time restructuring charge of about $1.5 million in the third quarter of 2026, primarily related to severance and other employee-related costs.
Tela Bio IncCOO/CFO departure and 20% headcount cut signal cost pressures and restructuring charge.
